bpc 157 peptide compounding pharmacy FDA advisory committee votes to add popular BPC-157 to drug list Ways2Well - Next week, July

Avoid high-fat meals, carbonated drinks, and large portions, especially on injection day

Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy

2.B12 is combined with a protein manufactured by your body called Intrinsic Factor (IF) and gets absorbed by your liver

Thiamine deficiency is well documented in individuals with chronic alcohol use and malabsorption conditions

What Is BPC-157, and How Does It Work

If you are administering B12 injections, choosing the appropriate needle is essential for a seamless, pain-free experience